Elevated tumor markers in patients with pulmonary alveolar proteinosis

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 7, 2013, Pages 1493-1498

  Fang, Shen Cun ^a   Lu, Kai Hua ^b   Wang, Cai Ying ^a   Zhang, Hai Tao ^a   Zhang, Ying Ming ^a  

^a NANJING CHEST HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

pulmonary alveolar proteinosis; tumor markers; whole lung lavage

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; KERATIN-19; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PULMONARY ALVEOLAR PROTEINOSIS; RETROSPECTIVE STUDIES; SERPINS; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL;

EID: 84882944691     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0738     Document Type: Article

References (16)

1. Khan A, Agarwal R. Pulmonary alveolar proteinosis. Respir Care 2011;56:1016-28.
2. Martinez-Moczygemba M, Huston DP. Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis. Curr Allergy Asthma Rep 2010;10:320-5.
3. Mukae H, Ishimoto H, Yanagi S, Ishii H, Nakayama S, Ashitani J, et al. Elevated BALF concentrations of alpha-and beta-defensins in patients with pulmonary alveolar proteinosis. Respir Med 2007;101:715-21.
4. Lin FC, Chen YC, Chang SC. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis. Mayo Clin Proc 2008;83:1344-9.
5. Hirakata Y, Kobayashi J, Sugama Y, Kitamura S. Elevation of tumor marker in serum and BALF in PAP. Eur Respir J 1995;8:689-96.
6. Sahin F, Yildiz P. Serum CA-125: Biomarker of pulmonary tuberculosis activity and evaluation of response to treatment. Clin Invest Med 2012;35:223-8.
7. Bulut I, Arbak P, Coskun A, Balbay O, Annakkaya AN, Yavuz O, et al. Comparison of serum CA 19.9, CA 125 and CEA levels with severity of chronic obstructive pulmonary disease. Med Princ Pract 2009;18:289-93.
8. Minakata Y, Kida Y, Nakanishi H, Nishimoto T, Yukawa S. Change in cytokeratin 19 fragment level according to the severity of pulmonary alveolar proteinosis. Intern Med 2001;40:1024-7. (Pubitemid 33041144)
9. Michaud G, Reddy C, Ernst A. Whole-lung lavage for pulmonary alveolar proteinosis. Chest 2009;136:1678-81.
10. Luisetti M, Kadija Z, Mariani F, Rodi G, Campo I, Trapnell BC. Therapy options in pulmonary alveolar proteinosis. Ther Adv Respir Dis 2010;4:239-48.
11. Fang CS, Wang YC, Zhang TH, Wu J, Wang W, Wang C, et al. Clinical significance of serum lipids in idiopathic pulmonary alveolar proteinosis. Lipids Health Dis 2012;11:1-7.
12. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215-35. (Pubitemid 34765459)
13. Fujishima T, Honda Y, Shijubo N, Takahashi H, Abe S. Increased carcinoembryonic antigen concentrations in sera and bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Respiration 1995;62:317-21.
14. Matsuoka Y, Endo K, Kawamura Y, Yoshida T, Saga T, Watanabe Y, et al. Normal bronchial mucus contains high levels of cancerassociated antigens, CA125, CA19-9, and carcinoembryonic antigen. Cancer 1990;65:506-10. (Pubitemid 20058368)
15. Wang E, Lin D, Wang Y, Wu G, Yuan X. Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma. Hum Pathol 2004;35:503-8. (Pubitemid 38507089)
16. Nakamura Y, Nakamura H, Matsuse A, Monden J, Shimoda T, Kawano S, et al. Interesting case of pulmonary alveolar proteinosis. Nihon Naika Gakkai Zasshi 1995;84:1909-11.